Chair of the Board · 10x Genomics, Inc. (TXG)

Chair, Audit Committee

John R. Stuelpnagel — 10x Genomics Director Compensation (2025)

Fiscal year 2025 director compensation for John R. Stuelpnagel at 10x Genomics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 24, 2026 (DEF 14A). Open the filing on EDGAR.

What they were paid

10x Genomics Director Compensation Table · all 2 fiscal years held
In US dollars, as 10x Genomics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$143,511$139,902$0$0$283,413
FY2024$131,657$186,645$0$0$318,302

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: 10x Genomics, Inc. DEF 14A filed April 24, 2026, accession 0001628280-26-027201, and prior-year filings. Open the filing on EDGAR.

Committees

FY2025 · as the proxy prints them

Audit (Chair) · Compensation · Mergers and Acquisitions

The rest of the 10x Genomics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Alan MateoIndependent Director$208,273
Benjamin J. HindsonDirector$0
Kimberly J. PopovitsIndependent Director$216,323
Sarah TeichmannIndependent Director$198,323
Serge SaxonovDirector$0
Shehnaaz SulimanIndependent Director$210,994
Sri KosarajuIndependent Director$223,323

The full 10x Genomics compensation record

free company brief

This page is one director within 10x Genomics's record. The company brief lists every named executive and director, each linking to their own page.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy